Your browser doesn't support javascript.
loading
Association of sleep disturbances with sarcopenia and its defining components: the ELSA-Brasil study.
Szlejf, C; Suemoto, C K; Drager, L F; Griep, R H; Fonseca, M J M; Diniz, M F H S; Lotufo, P A; Benseãor, I M.
Afiliación
  • Szlejf C; Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Suemoto CK; Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Drager LF; Divisão de Geriatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Griep RH; Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Fonseca MJM; Unidade de Hipertensão, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Diniz MFHS; Laboratório de Educação em Ambiente e Saúde, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.
  • Lotufo PA; Departamento de Epidemiologia e Métodos Quantitativos em Saúde, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.
  • Benseãor IM; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
Braz J Med Biol Res ; 54(12): e11539, 2021.
Article en En | MEDLINE | ID: mdl-34878063
ABSTRACT
Sarcopenia and sleep problems share common physiopathology. We aimed to investigate the association of sleep disturbances with sarcopenia and its defining components in Brazilian middle-aged and older adults. In this cross-sectional analysis of the second wave of the ELSA-Brasil study, we included data from 7948 participants aged 50 years and older. Muscle mass was evaluated by bioelectrical impedance analysis and muscle strength by hand-grip strength. Sarcopenia was defined according to the Foundation for the National Institutes of Health criteria. Sleep duration and insomnia complaint were self-reported. Short sleep duration was considered as ≤6 h/night and long sleep duration as >8 h/night. High risk of obstructive sleep apnea (OSA) was assessed using the STOP-Bang questionnaire. Possible confounders included socio-demographic characteristics, lifestyle, clinical comorbidities, and use of sedatives and hypnotics. The frequencies of sarcopenia, low muscle mass, and low muscle strength were 1.6, 21.1, and 4.1%, respectively. After adjustment for possible confounders, high risk of OSA was associated with low muscle mass (OR=2.17, 95%CI 1.92-2.45). Among obese participants, high risk of OSA was associated with low muscle strength (OR=1.68, 95%CI 1.07-2.64). However, neither short nor long sleep duration or frequent insomnia complaint were associated with sarcopenia or its defining components. In conclusion, high risk of OSA was associated with low muscle mass in the whole sample and with low muscle strength among obese participants. Future studies are needed to clarify the temporal relationship between both conditions.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos del Sueño-Vigilia / Sarcopenia Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged País/Región como asunto: America do norte / America do sul / Brasil Idioma: En Revista: Braz J Med Biol Res Año: 2021 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos del Sueño-Vigilia / Sarcopenia Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged País/Región como asunto: America do norte / America do sul / Brasil Idioma: En Revista: Braz J Med Biol Res Año: 2021 Tipo del documento: Article País de afiliación: Brasil